Medicine and Dentistry
Inflammatory Arthritis
100%
Rheumatoid Arthritis
99%
Disease
83%
Cohort Analysis
83%
Magnetic Resonance Imaging
82%
Emergency Department
69%
Multiple Sclerosis
69%
Spondylarthritis
62%
Randomized Controlled Trial
56%
Inflammatory Bowel Disease
53%
Infection
45%
Systematic Review
42%
Diagnosis
41%
Quality of Life
39%
Sacroiliac Joint
37%
COVID-19
36%
Prevalence
33%
Placebo
27%
Disease Activity
26%
Randomized Clinical Trial
24%
Ulcerative Colitis
24%
Comorbidity
23%
Cross Sectional Study
22%
Prospective Cohort Study
22%
Intensive Care Unit
21%
Outpatient
21%
Severe Acute Respiratory Syndrome Coronavirus 2
20%
Odds Ratio
20%
Meta-Analysis
20%
Crohn's Disease
20%
Rheumatic Disease
20%
Drug Therapy
18%
Biological Marker
17%
Patient-Reported Outcome
17%
Observational Study
17%
Symptomatic Treatment
16%
Patient Referral
16%
Knee
16%
Malignant Neoplasm
16%
Surgery
16%
Neoplasm
15%
Methotrexate
15%
Body Mass Index
15%
TNF Inhibitor
15%
Health Care
14%
Community-Acquired Pneumonia
14%
Cardiovascular Disease
14%
Hazard Ratio
14%
Postoperative Complication
14%
Ankylosing Spondylitis
13%
Colon Carcinoma
13%
Adverse Event
13%
Diagnostic Accuracy
13%
Prosthesis
13%
C Reactive Protein
13%
Triage
13%
Patient with Inflammatory Bowel Disease
12%
Lung
12%
Inflammatory Disorder
12%
Bone Marrow Edema
12%
Psoriatic Arthritis
12%
Low Back Pain
12%
Logistic Regression Analysis
12%
Tumor Necrosis Factor
12%
Laparoscopic Surgery
11%
Injury
11%
Intensive Care
11%
Case-Control Study
11%
Implant
11%
Clinical Trial
11%
Thorax Pain
11%
Clinician
11%
Acute Heart Infarction
11%
Multiple Myeloma
10%
Diabetes Mellitus
10%
Disease Course
10%
Scoring System
10%
Arm
10%
Colorectal Carcinoma
10%
Antibiotic Therapy
10%
Breast Cancer
10%
Alcohol Abstinence
10%
Dexamethasone
10%
Cancer Surgery
10%
Overall Survival
10%
Glucocorticoid
9%
Treatment Response
9%
Cardiovascular Risk
9%
Smoking
9%
Clinical Feature
9%
Osteoarthritis
9%
Disease Modifying Antirheumatic Drug
9%
Prospective Study
9%
Hip
9%
Arthritis
9%
Recurrent Disease
9%
Psoriasis
9%
Recurrence Risk
9%
Spontaneous Remission
8%
Atrial Fibrillation
8%
Pharmacology, Toxicology and Pharmaceutical Science
Inflammatory Arthritis
88%
Rheumatoid Arthritis
87%
Disease
80%
Multiple Sclerosis
75%
Cohort Study
66%
Infection
50%
Inflammatory Bowel Disease
50%
Placebo
39%
Disease Activity
36%
Prevalence
36%
Spondylarthritis
32%
Remission
30%
Randomized Controlled Trial
23%
Inflammation
21%
Crohn's Disease
20%
Cross-Sectional Study
20%
Biological Marker
18%
Acute Heart Infarction
18%
Cardiovascular Disease
18%
Rheumatic Disease
18%
Methotrexate
18%
SARS Coronavirus
17%
Tumor Necrosis Factor
17%
Randomized Clinical Trial
16%
Ulcerative Colitis
15%
Adalimumab
14%
Prospective Cohort Study
14%
Antibiotics
13%
Alirocumab
13%
Vitamin D
13%
Diabetes Mellitus
12%
Heart Infarction
12%
Colorectal Carcinoma
12%
Case-Control Study
12%
Comorbidity
12%
Coronavirinae
12%
Acute Coronary Syndrome
12%
Adverse Event
12%
Atrial Fibrillation
12%
Inflammatory Disease
11%
Clinical Trial
11%
Bloodstream Infection
10%
Glucocorticoid
10%
Side Effect
10%
Dexamethasone
10%
Kidney Disease
10%
Psoriatic Arthritis
9%
Bone Marrow Edema
9%
Cerebrovascular Accident
9%
Low Back Pain
9%
Disease Modifying Antirheumatic Drug
9%
Pandemic
9%
Monotherapy
9%
Biological Product
9%
Pregnancy Diabetes Mellitus
8%
Malignant Neoplasm
8%
C Reactive Protein
8%
Myelooptic Neuropathy
8%
4-Aminopyridine
8%
Thioridazine
8%
Placebo-Controlled Study
8%
Cardiovascular Risk
8%
Overall Survival
8%
Analgesic Agent
8%
Chronic Kidney Failure
8%
Thorax Pain
8%
Combination Therapy
7%
Non Small Cell Lung Cancer
7%
Breast Cancer
7%
Community Acquired Pneumonia
7%
Retrospective Study
7%
Medication Error
6%
Hip Fracture
6%
Anemia
6%
Postoperative Complication
6%
Congestive Heart Failure
6%
Multidrug Resistance
6%
Observational Study
6%
Cyclic Citrullinated Peptide Antibody
6%
Tumor Necrosis Factor Inhibitor
6%
Disease Activity Score
5%
Meningitis
5%
Pharmacotherapy
5%
Cytokine
5%
Disease Exacerbation
5%
Immune Checkpoint Inhibitor
5%
Neoplasm
5%
Sepsis
5%
Immunotherapy
5%
Parkinson's Disease
5%
Tumor Necrosis
5%
Disease Course
5%
Hypoxemia
5%
Hip Osteoarthritis
5%
Methicillin-Resistant Staphylococcus Aureus
5%
Effusion
5%
Arthritis
5%
Epidemiology
5%
Progression Free Survival
5%
All Cause Mortality
5%
Nursing and Health Professions
Inflammatory Arthritis
94%
Rheumatoid Arthritis
93%
Emergency Ward
70%
Multiple Sclerosis
43%
Cohort Analysis
38%
Disease
35%
Quality of Life
34%
Health Care Personnel
33%
Systematic Review
30%
Spondylarthritis
23%
Disease Activity
22%
Ward
22%
Diagnosis
19%
Palliative Therapy
18%
Cross-Sectional Study
18%
Confidence Interval
18%
Nuclear Magnetic Resonance Imaging
17%
Hospital
16%
Health Practitioner
15%
Inflammatory Bowel Disease
15%
Drug Therapy
15%
Prevalence
14%
Outpatient
14%
Patient Referral
13%
Intensive Care Unit
12%
Clinical Practice
12%
Prospective Cohort Study
11%
Gold Standard
11%
Patient-Reported Outcome
10%
Muscle Strength
10%
Health Service
10%
Meta Analysis
10%
Patient Education
9%
Arthritis
9%
End of Life Care
9%
Hospital Readmission
9%
Treatment Outcome
9%
Nicotine Withdrawal
9%
Physician
9%
General Practice
9%
Patient Safety
9%
Cardiovascular Risk
9%
Logistic Regression Analysis
8%
Home Care
8%
Rheumatic Disease
8%
Ankylosing Spondylitis
8%
Healthcare System
8%
Postoperative Complication
8%
Hip Fracture
8%
Acute Abdomen
8%
Cardiovascular Disease
8%
Triage
8%
General Practitioner
8%
Perioperative
8%
Remission
8%
Body Mass
8%
Comorbidity
8%
Pandemic
7%
Outpatient Department
7%
Functional Status
7%
Severe Acute Respiratory Syndrome
7%
Biological Product
7%
Intensive Care
7%
Odds Ratio
7%
Adverse Event
7%
Rheumatologist
7%
Practice Guideline
6%
Alcohol Consumption
6%
Parkinson's Disease
6%
Pelvic Organ Prolapse
6%
Length of Stay
6%
Self Care
6%
Elderly Patient
6%
DAS28
6%
Chronic Disease
6%
Patient Care
6%
Health Care Cost
6%
Gastroenteritis
6%
Frailty
5%
Occupation (Patient Social Context)
5%
Imaging
5%
Crohn's Disease
5%
Shared Decision-Making
5%
Inflammatory Disease
5%
Adolescent
5%
Combination Therapy
5%
Tumor Necrosis Factor Inhibitor
5%
Self-Efficacy
5%
Malignant Neoplasm
5%
Infection
5%
Short Form 36
5%
Analgesia
5%
Spinal Cord Injury
5%
Telemedicine
5%
Pressure Injury
5%
Fampridine
5%
Patient with Inflammatory Bowel Disease
5%